Inventor

THIERAUCH KARL-HEINZ

DE33 patents

⚠️ This page may combine multiple inventors who share the name “THIERAUCH KARL-HEINZ”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

THIERAUCH KARL-HEINZ

SCHERING AG

N-Aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF

9-halogen-(Z)-prostaglandin derivatives, process for their production and their use as pharmaceutical agents

Cyclodextrin clathrates of carbacyclin derivatives and their use as medicinal agents

Monoclonal antibodies against the extracellular domain of human VEGF-receptor protein (KDR)

Cyanoanthranilamide derivatives and the use thereof as medicaments

VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones

Anthranyl amides and their use as medicaments

VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines

9-halogen-(Z) prostaglandin derivatives, process for their production and their use as pharmaceutical agents

Cyclodextrin clathrates of 5-cyanoprostacyclin derivatives and their use as pharmaceutical agents

N-oxide anthranylamide derivatives and their use as medicaments

Ortho-substituted anthranilic acid amides and their use as medicaments

Bicyclo 3.3.0!octane derivatives, process for their production and their pharmaceutical use

Cyclopentane ether derivatives, processes for their production, and their pharmaceutical use

6-oxoprostaglandin E derivatives, process for their production and their pharmaceutical use

BAYER SCHERING PHARMA AG

VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines

Substituted pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same

Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors

Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors

Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same

Substituted sulphoximines as TIE2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same

VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines

Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors

Pyrazolopyridines and salts thereof, a pharmaceutical composition comprising said compounds, a method of preparing same and use of same

Substituted aminopyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same

NOVARTIS AG

Anthranilic acid amides and the use thereof as medicaments

VEGF receptor tyrosine kinase inhibitors

VEGF receptor tyrosine kinase inhibitors

Anthranylalkyl and cycloalkyl amides and use thereof as VEGF receptor inhibitors

Azanthranylalkyl and -cycloalkyl amides and their use as VEGF receptor inhibitors

SEATTLE GENETICS INC

Binder-drug conjugates (ADCs) and use thereof

BOYER STEPHEN

Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis

HARTUNG INGO

Alkynylaryl compounds and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same